Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Helpful or harmful? The impact of the ketogenic diet on eating disorder outcomes in type 1 diabetes mellitus.

Authors:
Suzanne Schneider Deborah L Biggerstaff Thomas M Barber

Expert Rev Endocrinol Metab 2022 Jul 24;17(4):319-331. Epub 2022 Jun 24.

Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Coventry, UK.

Introduction: Eating disorders (EDs) are common complications in people with type 1 diabetes (PwT1D), given the rigid focus on food and insulin dose adjustment. Dietary recommendations for T1D match those for the general population, yet many fail to achieve target HbA1c. Evidence suggests that lower carbohydrate meals and thus reduced insulin requirements may decrease inconsistencies in insulin absorption, maintain euglycemia and weight. Dietary restriction is a recognized risk factor for ED development, and Ketogenic Diets (KD) involve restriction of common family-based foods, thus impacting social normality and microbiome diversity. We reviewed the current literature on PwT1D following a KD to understand effects on ED risks.

Areas Covered: Published data from MEDLINE, Embase, and PsycINFO were used. Search terms included: type 1 diabetes mellitus; or insulin dependent diabetes or T1D AND EDs or anorexia or bulimia or disordered eating AND low-carbohydrate diet or carbohydrate restricted diet or low carb diet or ketogenic diet.

Expert Opinion: Research into the effects of KDs on ED outcomes in PwT1D are limited, given the concerns over risks of diabetic ketoacidosis, hypoglycemia, and dyslipidemia. Longer term studies on the participants' experience and motivations of adhering or admonishing the diet are needed.

Download full-text PDF

Source
http://dx.doi.org/10.1080/17446651.2022.2089112DOI Listing
July 2022

Publication Analysis

Top Keywords

type diabetes
12
diabetes mellitus
8
diet
5
diet needed
4
weight dietary
4
absorption maintain
4
embase psycinfo
4
maintain euglycemia
4
pwt1d limited
4
euglycemia weight
4
restriction recognized
4
dietary restriction
4
outcomes pwt1d
4
recognized risk
4
kds outcomes
4
risk factor
4
effects kds
4
factor development
4
limited concerns
4
insulin absorption
4

Keyword Occurance

Similar Publications

Immunotherapy for type 1 diabetes mellitus by adjuvant-free Schistosoma japonicum-egg tip-loaded asymmetric microneedle patch (STAMP).

Authors:
Haoming Huang Dian Hu Zhuo Chen Jiarong Xu Rengui Xu Yusheng Gong Zhengming Fang Ting Wang Wei Chen

J Nanobiotechnology 2022 Aug 13;20(1):377. Epub 2022 Aug 13.

National Demonstration Center for Experimental Basic Medical Education, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China.

Background: Type 1 diabetes mellitus (T1DM) is an autoimmune disease mediated by autoreactive T cells and dominated by Th1 response polarization. Insulin replacement therapy faces great challenges to this autoimmune disease, requiring highly frequent daily administration. Intriguingly, the progression of T1DM has proven to be prevented or attenuated by helminth infection or worm antigens for a relatively long term. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

A vegan diet improves insulin resistance in individuals with obesity: a systematic review and meta-analysis.

Authors:
Peng Chen Ying Zhao Yan Chen

Diabetol Metab Syndr 2022 Aug 13;14(1):114. Epub 2022 Aug 13.

Department of Endocrinology, The Second Hospital of Jilin University, No. 218, Ziqiang Street, Nanguan District, Changchun, China.

Background: A vegan diet has benefits on weight reduction and on the parameters of glucose and lipid metabolism. This meta-analysis aimed to investigate the efficacy of plant-based diets on insulin resistance and blood lipids in patients with obesity.

Methods: PubMed, Embase, and the Cochrane Library were searched for available papers published up to March 2021. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

High neutrophil to lymphocyte ratio with type 2 diabetes mellitus predicts poor prognosis in patients undergoing percutaneous coronary intervention: a large-scale cohort study.

Authors:
Jining He Xiaohui Bian Chenxi Song Rui Zhang Sheng Yuan Dong Yin Kefei Dou

Cardiovasc Diabetol 2022 Aug 13;21(1):156. Epub 2022 Aug 13.

State Key Laboratory of Cardiovascular Disease, Beijing, China.

Background: Inflammation plays a crucial role in the pathogenesis and progression of coronary artery disease (CAD). The neutrophil to lymphocyte ratio (NLR) is a novel inflammatory biomarker and its association with clinical outcomes in CAD patients with different glycemic metabolism after percutaneous coronary intervention (PCI) remains undetermined. Therefore, this study aimed to investigate the effect of NLR on the prognosis of patients undergoing PCI with or without type 2 diabetes mellitus (T2DM). Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Contemporary use of SGLT2 inhibitors in heart failure patients with diabetes mellitus: a comparison of DPP4 inhibitors in a nationwide electric health database of the superaged society.

Authors:
Michikazu Nakai Yoshitaka Iwanaga Koshiro Kanaoka Yoko Sumita Yuichi Nishioka Tomoya Myojin Shinichiro Kubo Katsuki Okada Tsunenari Soeda Tatsuya Noda Yasushi Sakata Tomoaki Imamura Yoshihiko Saito Satoshi Yasuda Yoshihiro Miyamoto

Cardiovasc Diabetol 2022 Aug 13;21(1):157. Epub 2022 Aug 13.

Open Innovation Center, National Cerebral and Cardiovascular Center, Suita, Japan.

Background: There is a lack of recent data reflecting the actual use of sodium-glucose cotransporter-2 (SGLT2) inhibitors for heart failure (HF) and type 2 diabetes (DM) in the superaged society. The present study investigated the association between the use of SGLT2 inhibitors and one-year prognosis in patients hospitalized across a broad spectrum of HF patients with DM in the superaged society using the Nationwide Electric Health Database in Japan.

Methods: The patients hospitalized with the first episode of acute HF were identified from the National Database of Health Insurance Claims and Specific Health Checkups of Japan between April 2014 and March 2019. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Association of Time in Range with Endothelial Injury in Patients with Type 2 Diabetes Treated with Exenatide.

Authors:
Yunyi Le Kun Yang Jin Yang Wei Fu Wenhua Xiao Rui Wei Tianpei Hong

Diabetes Ther 2022 Aug 13. Epub 2022 Aug 13.

Department of Endocrinology and Metabolism, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing, 100191, China.

Introduction: We aimed to investigate whether treatment with exenatide could increase time in range (TIR) and decrease glycemic variability, and to evaluate the association between TIR and endothelial injury in patients with type 2 diabetes mellitus (T2DM).

Methods: Two-hundred patients with T2DM treated with exenatide for 16 weeks were included in this study. Seven-point fingerstick blood glucose was used to evaluate derived TIR and glycemic variability. Read More

View Article and Full-Text PDF
August 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap